Glia in the cytokine-mediated onset of depression: fine tuning the immune response
Open accessThe DOI matches its Crossref record; 79 of the 79 references it cites were found in a registry or an index.
Abstract
Major depressive disorder (MDD) is a mood disorder of multifactorial origin affecting millions of people worldwide. The alarming estimated rates of prevalence and relapse make it a global public health concern. Moreover, the current setback of available antidepressants in the clinical setting is discouraging. Therefore, efforts to eradicate depression should be directed towards understanding the pathomechanisms involved in the hope of finding cost-effective treatment alternatives. The pathophysiology of MDD comprises the breakdown of different pathways, including the hypothalamus-pituitary-adrenal (HPA) axis, the glutamatergic system, and monoaminergic neurotransmission, affecting cognition and emotional behavior. Inflammatory cytokines have been postulated to be the possible link and culprit in the disruption of these systems. In addition, evidence from different studies suggests that impairment of glial functions appears to be a major contributor as well. Thus, the intricate role between glia, namely microglia and astrocytes, and the central nervous system's (CNSs) immune response is briefly discussed, highlighting the kynurenine pathway as a pivotal player. Moreover, evaluations of different treatment strategies targeting the inflammatory response are considered. The immuno-modulatory properties of vitamin D receptor (VDR) suggest that vitamin D is an attractive and plausible candidate in spite of controversial findings. Further research investigating the role of VDR in mood disorders is warranted.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
From inflammation to sickness and depression: when the immune system subjugates the brain
Dantzer, R., O'Connor, J. C., Freund, G. G., Johnson, R. W., & Kelley, K. W. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2297 · Cited by 7,395
A Meta-Analysis of Cytokines in Major Depression
Dowlati, Y., Herrmann, N., Swardfager, W., Liu, H., Sham, L., Reim, E. K., & Lanctôt, K. L. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.09.033 · Cited by 4,729
Colman (2022) · doi:10.1073/pnas · Cited by 4,370
Trivedi, M. H., Rush, A. J., Wisniewski, S. R., Nierenberg, A. A., Warden, D., Ritz, L., Norquist, G., Howland, R. H., Lebowitz, B., McGrath, P. J., et al. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.1.28 · Cited by 3,879 · cited 2×
“A recent longitudinal study conducted in England revealed that children with elevated serum IL-6 and CRP levels were more at risk to develop depression and psychosis later in life (Khandaker et al., 2014).”
BackgroundA randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.
Zarate, C. A., Singh, J. B., Carlson, P. J., Brutsche, N. E., Ameli, R., Luckenbaugh, D. A., Charney, D. S., & Manji, H. K. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.8.856 · Cited by 3,766
The size and burden of mental disorders and other disorders of the brain in Europe 2010
Wittchen, H. U., Jacobi, F., Rehm, J., Gustavsson, A., Svensson, M., Jönsson, B., Olesen, J., Allgulander, C., Alonso, J., Faravelli, C., et al. (2011) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2011.07.018 · Cited by 3,754
Cytokines sing the blues: inflammation and the pathogenesis of depression
Raison, C. L., Capuron, L., & Miller, A. H. (2006) · Trends in Immunology · doi:10.1016/j.it.2005.11.006 · Cited by 3,009
Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action
Tsankova, N. M., Berton, O., Renthal, W., Kumar, A., Neve, R. L., & Nestler, E. J. (2006) · Nature Neuroscience · doi:10.1038/nn1659 · Cited by 1,780
Rajkowska, G., Miguel-Hidalgo, J. J., Wei, J., Dilley, G., Pittman, S. D., Meltzer, H. Y., Overholser, J. C., Roth, B. L., & Stockmeier, C. A. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00041-4 · Cited by 1,477 · cited 2×
“Human post-mortem studies of mood disorder patients consistently demonstrate a significant decrease in the number of glia in the pre-frontal cortex and limbic structures of the brain (Rajkowska et al., 1999; Cotter et al., 2001; Bowley et al., 2002; Hamidi et al., 2004; Altshuler et al., 2010).”
BackgroundSo depression is an inflammatory disease, but where does the inflammation come from?
Berk, M., Williams, L. J., Jacka, F. N., O’Neil, A., Pasco, J. A., Moylan, S., Allen, N. B., Stuart, A. L., Hayley, A. C., Byrne, M. L., et al. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-200 · Cited by 1,423 · cited 3×
“From the genetic perspective, polymorphisms in the genes PSMB4 (proteasome β4 subunit) and TBX21 (T bet) that result in Tcell dysfunction, were reported to contribute to the pathology of MDD (Wong et al., 2008; Berk et al., 2013).”
BackgroundInfluentialChronic stress, glucocorticoid receptor resistance, inflammation, and disease risk
Cohen, S., Janicki-Deverts, D., Doyle, W. J., Miller, G. E., Frank, E., Rabin, B. S., & Turner, R. B. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1118355109 · Cited by 1,419 · cited 1×
“Chronic psychological stress is a well-studied risk factor suggested to induce GR resistance and trigger the inflammatory cascade (Miller et al., 2002; Raison et al., 2006; Cohen et al., 2012).”
BackgroundO'Connor, J. C., Lawson, M. A., André, C., Moreau, M., Lestage, J., Castanon, N., Kelley, K. W., & Dantzer, R. (2009) · Molecular Psychiatry · doi:10.1038/sj.mp.4002148 · Cited by 1,278
Gold, P. W., & Chrousos, G. P. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001032 · Cited by 1,274
Murrough, J. W., Iosifescu, D. V., Chang, L. C., Al Jurdi, R. K., Green, C. E., Perez, A. M., Iqbal, S., Pillemer, S., Foulkes, A., Shah, A., et al. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2013.13030392 · Cited by 1,205
Raison, C. L., & Miller, A. H. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.9.1554 · Cited by 1,197
Heim, C., & Binder, E. B. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2011.10.032 · Cited by 986
CRP, IL-6 and depression: a systematic review and meta-analysis of longitudinal studies.
Valkanova, V., Ebmeier, K. P., & Allan, C. L. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.06.004 · Cited by 972 · cited 1×
“Meta-analyses of studies associating inflammatory markers with MDD reported significantly higher levels of TNF-α, IL-6, and C-reactive protein (CRP) in depressed patients (Dowlati et al., 2010; Valkanova et al., 2013).”
BackgroundTikka, T., Fiebich, B. L., Goldsteins, G., Keinänen, R., & Koistinaho, J. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-08-02580.2001 · Cited by 958 · cited 1×
“Minocycline has been demonstrated to inhibit activation and proliferation of microglia, therefore regulating the immune response (Tikka et al., 2001; Henry et al., 2008).”
BackgroundAnderson, I. M. (2000) · Journal of Affective Disorders · doi:10.1016/s0165-0327(99)00092-0 · Cited by 940 · cited 1×
“Although their efficacy is comparable to the tricyclic antidepressants, the preferred choice for SSRIs arises from the fact that they are safer, have better tolerability, and lower rates of treatment discontinuation (Anderson, 2000).”
BackgroundKhandaker, G. M., Pearson, R. M., Zammit, S., Lewis, G., & Jones, P. B. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.1332 · Cited by 846 · cited 1×
“A recent longitudinal study conducted in England revealed that children with elevated serum IL-6 and CRP levels were more at risk to develop depression and psychosis later in life (Khandaker et al., 2014).”
BackgroundVitamin D deficiency and depression in adults: systematic review and meta-analysis
Anglin, R. E. S., Samaan, Z., Walter, S. D., & McDonald, S. D. (2013) · British Journal of Psychiatry · doi:10.1192/bjp.bp.111.106666 · Cited by 820
Müller, N., Schwarz, M. J., Dehning, S., Douhe, A., Cerovecki, A., Goldstein-Müller, B., Spellmann, I., Hetzel, G., Maino, K., Kleindienst, N., et al. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001805 · Cited by 794
Functional antagonists at the NMDA receptor complex exhibit antidepressant actions
Trullas, R., & Skolnick, P. (1990) · European Journal of Pharmacology · doi:10.1016/0014-2999(90)90204-j · Cited by 785 · cited 1×
“MDD also compromises the glutamatergic system characterized by the increased activation of NMDAr (Trullas and Skolnick, 1990).”
BackgroundMiller, G. E., Cohen, S., & Ritchey, A. K. (2002) · Health Psychology · doi:10.1037/0278-6133.21.6.531 · Cited by 769 · cited 2×
“Supporting this notion, it was shown in parallel that chronic unpredictable stress in mice led to depressive-like behavior such as decrease in sucrose consumption and social exploration along with microglial proliferation and activation, ending in subsequent microglial apoptosis (Kreisel et al.,…”
BackgroundResultCotter, D., Mackay, D., Landau, S., Kerwin, R., & Everall, I. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.6.545 · Cited by 766
Agudelo, L. Z., Femenía, T., Orhan, F., Porsmyr-Palmertz, M., Goiny, M., Martinez-Redondo, V., Correia, J. C., Izadi, M., Bhat, M., Schuppe-Koistinen, I., et al. (2014) · Cell · doi:10.1016/j.cell.2014.07.051 · Cited by 739
Henry, C. J., Huang, Y., Wynne, A., Hanke, M., Himler, J., Bailey, M. T., Sheridan, J. F., & Godbout, J. P. (2008) · Journal of Neuroinflammation · doi:10.1186/1742-2094-5-15 · Cited by 678 · cited 9×
“Minocycline has been demonstrated to inhibit activation and proliferation of microglia, therefore regulating the immune response (Tikka et al., 2001; Henry et al., 2008).”
BackgroundInfluentialThe immune-mediated alteration of serotonin and glutamate: towards an integrated view of depression
Müller, N., & Schwarz, M. J. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4002006 · Cited by 670
Kreisel, T., Frank, M. G., Licht, T., Reshef, R., Ben-Menachem-Zidon, O., Baratta, M. V., Maier, S. F., & Yirmiya, R. (2014) · Molecular Psychiatry · doi:10.1038/mp.2013.155 · Cited by 663
Raison, C. L., Dantzer, R., Kelley, K. W., Lawson, M. A., Woolwine, B. J., Vogt, G., Spivey, J. R., Saito, K., & Miller, A. H. (2010) · Molecular Psychiatry · doi:10.1038/mp.2009.116 · Cited by 630 · cited 12×
“Moreover, studies evaluating the KYN pathway in the periphery have reported an increased KYN/KA ratio associated with depressive symptoms in individuals with HCV treated with IFN-α, and a reduced KA/QUIN ratio in MDD patients compared with controls (Wichers et al., 2005; Savitz et al., 2015).”
BackgroundInfluentialNemets, B., Stahl, Z., & Belmaker, R. H. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.3.477 · Cited by 627
Pace, T. W. W., Hu, F., & Miller, A. H. (2007) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2006.08.009 · Cited by 621
Endotoxin produces a depressive-like episode in rats
Yirmiya, R. (1996) · Brain Research · doi:10.1016/0006-8993(95)01415-2 · Cited by 604 · cited 2×
“…hypothesis of depression, studies using animal models have demonstrated that administering lipopolysaccharides (LPS) as well as pro-inflammatory cytokines induce depressive-like behaviors such as anhedonia, assessed by sucrose/saccharine preference tests (Yirmiya, 1996; De La Garza, 2005).”
BackgroundResultThe glucocorticoid receptor: Pivot of depression and of antidepressant treatment?
Anacker, C., Zunszain, P. A., Carvalho, L. A., & Pariante, C. M. (2011) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2010.03.007 · Cited by 592 · cited 1×
“In addition, GR resistance promotes hyperactivation of the HPA axis leading to the overproduction of glucocorticoids, hallmark features of MDD (Anacker et al., 2011).”
BackgroundAutoimmune Diseases and Severe Infections as Risk Factors for Mood Disorders: A Nationwide Study
Benros, M. E., Waltoft, B. L., Nordentoft, M., Østergaard, S. D., Eaton, W. W., Krogh, J., & Mortensen, P. B. (2013) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.1111 · Cited by 572
Steiner, J., Walter, M., Gos, T., Guillemin, G. J., Bernstein, H.-G., Sarnyai, Z., Mawrin, C., Brisch, R., Bielau, H., zu Schwabedissen, L., et al. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-94 · Cited by 568
Torres-Platas, S. G., Cruceanu, C., Chen, G. G., Turecki, G., & Mechawar, N. (2014) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2014.05.007 · Cited by 545 · cited 1×
“In human post-mortem studies, higher microglial activation was observed in different regions including anterior cingulate cortex, pre-frontal cortex and hippocampus of depressed suicides (Steiner et al., 2008; Torres-Platas et al., 2014).”
BackgroundMajor depression and comorbid substance use disorders
Davis, L., Uezato, A., Newell, J. M., & Frazier, E. (2008) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e3282f32408 · Cited by 498
Guillemin, G. J., Smythe, G., Takikawa, O., & Brew, B. J. (2005) · Glia · doi:10.1002/glia.20090 · Cited by 497 · cited 1×
“Conversely, astrocytes exclusively express kynurenine aminotransferases, which are essential in the conversion of KYN to KA (Guillemin et al., 2001, 2005).”
BackgroundCapuron, L., Ravaud, A., Neveu, P. J., Miller, A. H., Maes, M., & Dantzer, R. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4000995 · Cited by 473 · cited 1×
“Furthermore, several studies report that cytokine therapy, such as IFN-α, can generate depressive and manic symptoms in HCV and cancer patients (Bonaccorso et al., 2002; Capuron et al., 2002; Constant et al., 2005).”
BackgroundBanasr, M., Chowdhury, G. M. I., Terwilliger, R., Newton, S. S., Duman, R. S., Behar, K. L., & Sanacora, G. (2010) · Molecular Psychiatry · doi:10.1038/mp.2008.106 · Cited by 458
Vitamin D3: a helpful immuno-modulator: Vitamin D3 as immuno-modulator
Di Rosa, M., Malaguarnera, M., Nicoletti, F., & Malaguarnera, L. (2011) · Immunology · doi:10.1111/j.1365-2567.2011.03482.x · Cited by 447 · cited 2×
“VDR is expressed in more than 38 types of cells, including immune cells (e.g., monocytes, dendritic cells, activated B and T cells) and CNS cells (e.g., neurons, astrocytes, and microglia; Di Rosa et al., 2011; Cui et al., 2013; Smolders et al., 2013).”
BackgroundWichers, M. C., Koek, G. H., Robaeys, G., Verkerk, R., Scharpé, S., & Maes, M. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001600 · Cited by 445 · cited 1×
“Moreover, studies evaluating the KYN pathway in the periphery have reported an increased KYN/KA ratio associated with depressive symptoms in individuals with HCV treated with IFN-α, and a reduced KA/QUIN ratio in MDD patients compared with controls (Wichers et al., 2005; Savitz et al., 2015).”
ResultResilience to social stress coincides with functional DNA methylation of the Crf gene in adult mice
Elliott, E., Ezra-Nevo, G., Regev, L., Neufeld-Cohen, A., & Chen, A. (2010) · Nature Neuroscience · doi:10.1038/nn.2642 · Cited by 436
Dahl, J., Ormstad, H., Aass, H. C. D., Malt, U. F., Bendz, L. T., Sandvik, L., Brundin, L., & Andreassen, O. A. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.03.019 · Cited by 424 · cited 2×
“An increasing amount of clinical evidence has shown the presence of augmented levels of proinflammatory markers in the periphery and in the CNS (Maes et al., 1993; Rotter et al., 2013; Dahl et al., 2014).”
BackgroundEpigenetics of the depressed brain: role of histone acetylation and methylation
Sun, H., Kennedy, P. J., & Nestler, E. J. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2012.73 · Cited by 413 · cited 1×
“Similar mechanisms were proposed to occur in depressed patients as evidenced by post-mortem brain and serological studies (Cruceanu et al., 2013; Sun et al., 2013).”
Glial reduction in amygdala in major depressive disorder is due to oligodendrocytes
Hamidi, M., Drevets, W. C., & Price, J. L. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2003.11.006 · Cited by 369 · cited 3×
“Oligodendrocytic dysfucntion in mood disorders is evidenced by human post-mortem studies reporting reduced numbers of oligodendrocytes in the pre-frontal cortex and amygdala (Hamidi et al., 2004; Uranova et al., 2004).”
BackgroundLugo-Huitrón, R., Blanco-Ayala, T., Ugalde-Muñiz, P., Carrillo-Mora, P., Pedraza-Chaverrí, J., Silva-Adaya, D., Maldonado, P. D., Torres, I., Pinzón, E., Ortiz-Islas, E., et al. (2011) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2011.07.002 · Cited by 346
Response to psychotherapy in borderline personality disorder and methylation status of the BDNF gene
Perroud, N., Salzmann, A., Prada, P., Nicastro, R., Hoeppli, M.-E., Furrer, S., Ardu, S., Krejci, I., Karege, F., & Malafosse, A. (2013) · Translational Psychiatry · doi:10.1038/tp.2012.140 · Cited by 320
Fetahu, I. S., Höbaus, J., & Kállay, E. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00164 · Cited by 313 · cited 3×
“Subsequently, the VDR-RXR complex formed binds to vitamin D responsive elements in the DNA to activate or repress the expression of vitamin D target genes (Fetahu et al., 2014).”
BackgroundInfluentialBay-Richter, C., Linderholm, K. R., Lim, C. K., Samuelsson, M., Träskman-Bendz, L., Guillemin, G. J., Erhardt, S., & Brundin, L. (2015) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2014.07.012 · Cited by 304 · cited 1×
“Augmented inhibition of the NMDAr by KA appears to cause changes in the glutamatergic system affecting the dopaminergic neurotransmission, a hallmark feature of schizophrenia (Wu et al., 2007; Pocivavsek et al., 2011).”
BackgroundAstrocytic abnormalities and global DNA methylation patterns in depression and suicide
Nagy, C., Suderman, M., Yang, J., Szyf, M., Mechawar, N., Ernst, C., & Turecki, G. (2015) · Molecular Psychiatry · doi:10.1038/mp.2014.21 · Cited by 301
Maier, S. F. (2003) · Brain Behavior and Immunity · doi:10.1016/s0889-1591(03)00032-1 · Cited by 300 · cited 2×
“Oligodendrocytic dysfucntion in mood disorders is evidenced by human post-mortem studies reporting reduced numbers of oligodendrocytes in the pre-frontal cortex and amygdala (Hamidi et al., 2004; Uranova et al., 2004).”
Wong, M.-L., Dong, C., Maestre-Mesa, J., & Licinio, J. (2008) · Molecular Psychiatry · doi:10.1038/mp.2008.59 · Cited by 295
The evolutionary significance of depression in Pathogen Host Defense (PATHOS-D)
Raison, C. L., & Miller, A. H. (2013) · Molecular Psychiatry · doi:10.1038/mp.2012.2 · Cited by 253 · cited 1×
“The loss of perineuronal oligodendrocytes was reported in the pre-frontal cortex of mood disorders and schizophrenia (Vostrikov et al., 2007; Szuchet et al., 2011).”
BackgroundVostrikov, V. M., Uranova, N. A., & Orlovskaya, D. D. (2007) · Schizophrenia Research · doi:10.1016/j.schres.2007.04.014 · Cited by 233 · cited 1×
“The loss of perineuronal oligodendrocytes was reported in the pre-frontal cortex of mood disorders and schizophrenia (Vostrikov et al., 2007; Szuchet et al., 2011).”
BackgroundShaffer, J. A., Edmondson, D., Wasson, L. T., Falzon, L., Homma, K., Ezeokoli, N., Li, P., & Davidson, K. W. (2014) · Psychosomatic Medicine · doi:10.1097/psy.0000000000000044 · Cited by 227 · cited 1×
“In addition, the largest effect was achieved when vitamin D was administered as an adjuvant (Shaffer et al., 2014).”
BackgroundBehan, W. M. H., McDonald, M., Darlington, L. G., & Stone, T. W. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702940 · Cited by 225 · cited 1×
“Furthermore, several studies indicate that QUIN toxicity can also lead to lipid peroxidation and nitrosative stress (Behan et al., 1999; Aguilera et al., 2007).”
BackgroundGlial and glutamatergic markers in depression, alcoholism, and their comorbidity
Miguel-Hidalgo, J. J., Waltzer, R., Whittom, A. A., Austin, M. C., Rajkowska, G., & Stockmeier, C. A. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2010.06.003 · Cited by 218
Coverage of Blood Vessels by Astrocytic Endfeet Is Reduced in Major Depressive Disorder
Rajkowska, G., Hughes, J., Stockmeier, C. A., Javier Miguel-Hidalgo, J., & Maciag, D. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.09.024 · Cited by 209 · cited 1×
“Accumulating data from human post-mortem studies of depressed patients reveal a significant decrease in the number of astroglial cells and less coverage of blood vessels by astrocytic end-feet (Johnston-Wilson et al., 2000; Gittins and Harrison, 2011; Rajkowska et al., 2013).”
BackgroundD'Addario, C., Dell'Osso, B., Palazzo, M. C., Benatti, B., Lietti, L., Cattaneo, E., Galimberti, D., Fenoglio, C., Cortini, F., Scarpini, E., et al. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.10 · Cited by 192
Cui, X., Pelekanos, M., Liu, P.-Y., Burne, T. H. J., McGrath, J. J., & Eyles, D. W. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.01.035 · Cited by 182 · cited 1×
“VDR is expressed in more than 38 types of cells, including immune cells (e.g., monocytes, dendritic cells, activated B and T cells) and CNS cells (e.g., neurons, astrocytes, and microglia; Di Rosa et al., 2011; Cui et al., 2013; Smolders et al., 2013).”
BackgroundInhibition of glial inflammatory activation and neurotoxicity by tricyclic antidepressants
Hwang, J., Zheng, L. T., Ock, J., Lee, M. G., Kim, S.-H., Lee, H.-W., Lee, W.-H., Park, H.-C., & Suk, K. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.06.045 · Cited by 181 · cited 1×
“Studies assessing fluoxetine and the tricyclic antidepressants clomipramine and imipramine demonstrated that these agents are capable of modulating the immune response by inhibiting the activation of glial cells in cell culture models (Hwang et al., 2008; Obuchowicz et al., 2014).”
BackgroundTadić, A., Müller-Engling, L., Schlicht, K. F., Kotsiari, A., Dreimüller, N., Kleimann, A., Bleich, S., Lieb, K., & Frieling, H. (2014) · Molecular Psychiatry · doi:10.1038/mp.2013.58 · Cited by 175 · cited 2×
“Furthermore, epigenetic modifications in the gene promoter region of BDNF in mood disorder patients have been shown by several studies to affect the patient’s response to the treatment received (D’Addario et al., 2012; Lopez et al., 2013; Tadíc et al., 2014).”
BackgroundDe La Garza, R. (2005) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2005.03.016 · Cited by 153
VDR gene variants associate with cognitive function and depressive symptoms in old age
Kuningas, M., Mooijaart, S. P., Jolles, J., Slagboom, P. E., Westendorp, R. G. J., & van Heemst, D. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.07.001 · Cited by 149
Anderson, H. D., Pace, W. D., Libby, A. M., West, D. R., & Valuck, R. J. (2012) · Clinical Therapeutics · doi:10.1016/j.clinthera.2011.11.024 · Cited by 147 · cited 2×
“Once inside, glutamate is further converted to glutamine by the enzyme glutamine synthase (Anderson and Swanson, 2000).”
BackgroundRessler, K. J., Bradley, B., Mercer, K. B., Deveau, T. C., Smith, A. K., Gillespie, C. F., Nemeroff, C. B., Cubells, J. F., & Binder, E. B. (2010) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.31052 · Cited by 140 · cited 1×
“For instance, it was demonstrated in one study that interactions between experiences of childhood abuse and genetic variations of both serotonin transporter and corticotrophin receptor 1 genes lead to the development of MDD (Ressler et al., 2010).”
BackgroundDifferences in cytokines between non-suicidal patients and suicidal patients in major depression
Kim, Y.-K., Lee, S.-W., Kim, S.-H., Shim, S.-H., Han, S.-W., Choi, S.-H., & Lee, B.-H. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.08.041 · Cited by 140
Wang, X., Wu, H., & Miller, A. H. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001339 · Cited by 128 · cited 1×
“A number of cytokines, such as IL-1α, TNF-α and IFN-α, have been reported to inhibit GR function (Wang et al., 2004; Hu et al., 2009; Van Bogaert et al., 2011).”
BackgroundInflammation and reactivation of latent herpesviruses in older adults
Bennett, J. M., Glaser, R., Malarkey, W. B., Beversdorf, D. Q., Peng, J., & Kiecolt-Glaser, J. K. (2012) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2011.11.007 · Cited by 118
Cruceanu, C., Alda, M., Nagy, C., Freemantle, E., Rouleau, G. A., & Turecki, G. (2013) · International Journal of Neuropsychopharmacology · doi:10.1017/s1461145712000363 · Cited by 93
Mavrides, N., & Nemeroff, C. (2013) · Depression and Anxiety · doi:10.1002/da.22051 · Cited by 85 · cited 2×
“Among some of the most frequently associated disorders are cardiovascular disease, cancer, diabetes, obesity, attention deficit hyperactivity disorder, and Alzheimer’s disease (Schillani et al., 2012; Hannon et al., 2013; Mavrides and Nemeroff, 2013; Wuwongse et al., 2013; Di Trani et al., 2014).”
BackgroundKlomp, A., Václavů, L., Meerhoff, G. F., Reneman, L., & Lucassen, P. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0097603 · Cited by 65
In vivo quinolinic acid increases synaptosomal glutamate release in rats: reversal by guanosine
Tavares, R. G., Schmidt, A. P., Abud, J., Tasca, C. I., & Souza, D. O. (2005) · Neurochemical Research · doi:10.1007/s11064-005-2678-0 · Cited by 59
Dean, O. M., Maes, M., Ashton, M., Berk, L., Kanchanatawan, B., Sughondhabirom, A., Tangwongchai, S., Ng, C., Dowling, N., Malhi, G. S., et al. (2014) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2014.12.3.180 · Cited by 58 · cited 2×
“In the CNS, vitamin D can act as an immune-regulator, and as stimulator of neurotrophic factors and neurotransmitters expression (Di Rosa et al., 2011; Eyles et al., 2011; Gezen-Ak et al., 2011).”
BackgroundWilde, A., Chan, H.-N., Rahman, B., Meiser, B., Mitchell, P. B., Schofield, P. R., & Green, M. J. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.01.014 · Cited by 55
The genetic signature of perineuronal oligodendrocytes reveals their unique phenotype
Szuchet, S., Nielsen, J. A., Lovas, G., Domowicz, M. S., de Velasco, J. M., Maric, D., & Hudson, L. D. (2011) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2011.07922.x · Cited by 53
Relationships Between Multiple Sclerosis and Depression
Byatt, N., Rothschild, A. J., Riskind, P., Ionete, C., & Hunt, A. T. (2011) · The Journal of Neuropsychiatry and Clinical Neurosciences · doi:10.1176/jnp.23.2.jnp198 · Cited by 51
Cited by
Brites, D., & Fernandes, A. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00476 · Cited by 599
“Characteristic pathophysiological hallmark features include monoamine depletion, down-regulation of neurotrophin signaling, and glucocorticoid receptor (GR) resistance, as well as excess of glutamate, corticotrophinreleasing hormone and cortisol levels (Carvalho et al., 2015; Jo et al., 2015).”
BackgroundWon, E., & Kim, Y.-K. (2016) · Current Neuropharmacology · doi:10.2174/1570159x14666151208113006 · Cited by 300
“Recent reviews have reported the associations among the KYN pathway, inflammatory cytokines and neurotoxicity of KYN pathway metabolites in depression [99, 100].”
BackgroundSwitching of the Microglial Activation Phenotype Is a Possible Treatment for Depression Disorder
Zhang, L., Zhang, J., & You, Z. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00306 · Cited by 280
Neuron secrete exosomes containing miR-9-5p to promote polarization of M1 microglia in depression
Xian, X., Cai, L.-L., Li, Y., Wang, R.-C., Xu, Y.-H., Chen, Y.-J., Xie, Y.-H., Zhu, X.-L., & Li, Y.-F. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01332-w · Cited by 169
“Background An estimated 350 million people worldwide are impacted by depression (also known as major depressive disorder, MDD), a multifaceted mood disorder which associated to both environmental and genetic factors [1].”
BackgroundHe, M.-C., Shi, Z., Sha, N.-N., Chen, N., Peng, S.-Y., Liao, D.-F., Wong, M.-S., Dong, X.-L., Wang, Y.-J., Yuan, T.-F., et al. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.01.021 · Cited by 54
Self-citation
Metadata
- Authors
- Jo, W. K., Zhang, Y., Emrich, H. M., & Dietrich, D. E.
- Venue
- Frontiers in Cellular Neuroscience
- Publisher
- Frontiers Media SA
- Published
- 2015-07-10
- Volume
- 9
- Pages
- 268-268
- ISSN
- 1662-5102 (ISSN-L)
- OpenAlex
- W1500090786
- Cited by
- 77
- References
- 79
- FWCI
- 2.10
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.